A Study to Evaluate LY3202328 in Overweight Healthy Participants and Dyslipidemia

NCT02714569 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Dyslipidemias

Interventions

DRUG: LY3202328
DRUG: Placebo
DRUG: Atorvastatin
DRUG: Simvastatin

Sponsor

Eli Lilly and Company